The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival

被引:153
作者
D'Souza, Warren N.
Chang, Chiung-Fang
Fischer, April M.
Li, Manqing
Hedrick, Stephen M. [1 ]
机构
[1] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
D O I
10.4049/jimmunol.181.11.7617
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The magnitude of T cell responses is determined by proliferation and survival decisions made by the responding cells. We now demonstrate that the Erk MAPK pathway plays a critical role in these cell fate decisions within CD8 T cells. While Erk1 is dispensable for all aspects of CD8 T cell activation, Erk2 is required for the proliferation or CD8 T cells activated in the absence of costimulation. Surprisingly, Erk2 is not required for proliferation following the addition of a costimulatory signal in vitro, or upon viral infection in vivo, but regulates the size of the responding population by enhancing cell survival. An important component or this Erk2-derived signal is the transcriptional regulation of Bcl-2 family members Bcl-x(L) and Bim, and impaired Erk2-deficient CD8 T cell survival can be rescued by genetic ablation or Bim. These studies ascribe multifaceted functions specific to Erk2 in CD8 T cell activation, proliferation, and survival. The Journal of Immunology, 2008, 181: 7617-7629.
引用
收藏
页码:7617 / 7629
页数:13
相关论文
共 65 条
  • [1] ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis
    Agrawal, Anshu
    Dillon, Stephanie
    Denning, Timothy L.
    Pulendran, Bali
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (10) : 5788 - 5796
  • [2] The Ras/MAPK cascade and the control of positive selection
    Alberola-Ila, J
    Hernández-Hoyos, G
    [J]. IMMUNOLOGICAL REVIEWS, 2003, 191 (01) : 79 - 96
  • [3] Positive and negative selection invoke distinct signaling pathways
    AlberolaIla, J
    Hogquist, KA
    Swan, KA
    Bevan, MJ
    Perlmutter, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) : 9 - 18
  • [4] SELECTIVE REQUIREMENT FOR MAP KINASE ACTIVATION IN THYMOCYTE DIFFERENTIATION
    ALBEROLAILA, J
    FORBUSH, KA
    SEGER, R
    KREBS, EG
    PERLMUTTER, RM
    [J]. NATURE, 1995, 373 (6515) : 620 - 623
  • [5] c-Jun NH2-terminal kinase (JNK)1 and JNK2 signaling pathways have divergent roles in CD8+ T cell-mediated antiviral immunity
    Arbour, N
    Naniche, D
    Homann, D
    Davis, RJ
    Flavell, RA
    Oldstone, MBA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (07) : 801 - 810
  • [6] Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1
    Asada, Sachie
    Daitoku, Hiroaki
    Matsuzaki, Hitomi
    Saito, Tomoko
    Sudo, Tatsuhiko
    Mukai, Hidehito
    Iwashita, Shintaro
    Kako, Koichiro
    Kishi, Tsutomu
    Kasuya, Yoshitoshi
    Fukamizu, Akiyoshi
    [J]. CELLULAR SIGNALLING, 2007, 19 (03) : 519 - 527
  • [7] The many paths to p38 mitogen-activated protein kinase activation in the immune system
    Ashwell, Jonathan D.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (07) : 532 - 540
  • [8] Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade
    Bain, G
    Cravatt, CB
    Loomans, C
    Alberola-Ila, J
    Hedrick, SM
    Murre, C
    [J]. NATURE IMMUNOLOGY, 2001, 2 (02) : 165 - 171
  • [9] Protein kinase C-θ is an early survival factor required for differentiation of effector CD8+ T cells
    Barouch-Bentov, R
    Lemmens, EE
    Hu, JR
    Janssen, EM
    Droin, NM
    Song, JX
    Schoenberger, SP
    Altman, A
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (08) : 5126 - 5134
  • [10] Massive expansion of antigen-specific CD8+ T cells during an acute virus infection
    Butz, EA
    Bevan, MJ
    [J]. IMMUNITY, 1998, 8 (02) : 167 - 175